Linda in Windsor Castle
Protected by Gurkas
The Queen was not at home
“If we understand it, we can fix it.”
With those
words, Dr. Robert Eisenman of Fred Hutch reinforces my firm belief that
continued work on the basic biology of cancer is valuable and ought to be
richly and intelligently supported.
Dr. Eisenman
works on the potential oncogene Myc.
Faithful readers will recognize this biological object; I have written
about it several times before. I still
don’t understand what it does, but it is clear that – when mutated – it is
implicit in cancer growth. You can’t go after
Myc directly, for several reasons, but apparently you can go after a protein
called MondoA which mutated Myc needs to do its job in cancer – which is, to
create material for cell growth. MondoA
is not necessary to healthy cells, it seems, so it is a fine target for an
anti-cancer drug. The Hutch people apparently
already have located such drugs (orphan drugs?) and tested them on mice,
successfully. Unfortunately, “the human
impact of these findings are years away”.
Again, an excess of caution – in my view.
Here is the
article. It is only one page long, so
read it.
http://www.fredhutch.org/en/news/center-news/2015/02/uncovering-cancers-metabolic-quirks.html
I have
tangled with Myc several times, most notably on 7/2/12 and 10/3/12. As you will see,Myc won on each occasion.
No comments:
Post a Comment